Release Date: 27/07/10 12:15 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 31.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%